英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:

abetted    音标拼音: [əb'ɛtɪd]
Abet \A*bet"\, v. t. [imp. & p. p. {Abetted}; p. pr. & vb. n.
{Abetting}.] [OF. abeter; a (L. ad) beter to bait (as a
bear), fr. Icel. beita to set dogs on, to feed, originally,
to cause to bite, fr. Icel. b[imac]ta to bite, hence to bait,
to incite. See {Bait}, {Bet}.]
1. To instigate or encourage by aid or countenance; -- used
in a bad sense of persons and acts; as, to abet an
ill-doer; to abet one in his wicked courses; to abet vice;
to abet an insurrection. "The whole tribe abets the
villany." --South.
[1913 Webster]

Would not the fool abet the stealth,
Who rashly thus exposed his wealth? --Gay.
[1913 Webster]

2. To support, uphold, or aid; to maintain; -- in a good
sense. [Obs.].

Our duty is urged, and our confidence abetted.
--Jer. Taylor.
[1913 Webster]

3. (Law) To contribute, as an assistant or instigator, to the
commission of an offense.
[1913 Webster]

Syn: To incite; instigate; set on; egg on; foment; advocate;
countenance; encourage; second; uphold; aid; assist;
support; sustain; back; connive at.
[1913 Webster]



安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Bamlanivimab - Wikipedia
    Bamlanivimab is an IgG1 monoclonal antibody (mAb) directed against the spike protein of SARS-CoV-2 [12] The aim is to block viral attachment and entry into human cells, thus neutralizing the virus, and help preventing and treating COVID-19
  • Bamlanivimab - StatPearls - NCBI Bookshelf
    Bamlanivimab is a monoclonal antibody (mAb) directed against the spike protein (S-Protein) of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Bamlanivimab, or LY-COV555, was derived from the convalescent plasma of patients with coronavirus disease 2019 (COVID-19) [1]
  • FACT SHEET FOR HEALTH CARE PROVIDERS EMERGENCY USE AUTHORIZATION (EUA . . .
    Bamlanivimab is available as a solution and must be diluted prior to administration Administer bamlanivimab 700 mg as a single IV infusion via pump or gravity (see Table 1) Clinically monitor patients during administration and observe patients for at least 1 hour after infusion is complete
  • FDA authorizes bamlanivimab and etesevimab for COVID-19
    In this revision of the EUA, bamlanivimab and etesevimab, administered together, are authorized for use after exposure to the virus and are not authorized for pre-exposure prophylaxis to prevent
  • Bamlanivimab etesevimab - Wikipedia
    Bamlanivimab is an IgG1 monoclonal antibody (mAb) directed against the spike protein of SARS‑CoV‑2 The aim is to block viral attachment and entry into human cells, thus neutralizing the virus, and help preventing and treating COVID-19
  • Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
    Two such neutralizing monoclonal antibodies, bamlanivimab and etesevimab, were isolated from convalescent plasma obtained from patients with Covid-19 in the United States and China, respectively
  • An overview of the preclinical discovery and development of . . .
    Bamlanivimab (LY-CoV555) is a mAb developed with this rationale by AbCellera Biologics and Eli Lilly as a treatment for COVID-19 This mAb was developed starting from convalescent plasma donated from a recovered 35 years-old COVID-19 patient
  • Frequently Asked Questions on the Emergency Use Authorization for . . .
    Q Is bamlanivimab approved by the FDA to treat COVID-19? A No Bamlanivimab is an investigational drug It is not currently FDA-approved to treat any diseases or conditions, including
  • An EUA for Bamlanivimab—A Monoclonal Antibody for COVID-19
    Monoclonal antibodies, such as bamlanivimab, may be associated with worse clinical outcomes when administered to hospitalized patients with COVID-19 requiring high flow oxygen or mechanical ventilation





中文字典-英文字典  2005-2009